- Serum Institute seeks Emergency Use Authorisation for COVID-19 vaccine
- Clinical trials were conducted at JSS Medical College in Mysuru in August
New Delhi: The Serum Institute of India (SII) yesterday became the country’s first company to apply to the Drugs Controller General of India (DCGI) seeking Emergency Use Authorisation (EUA) for the Oxford COVID-19 vaccine in India.






